Using blood tests to detect cancer earlier
Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Data Management and Coordinating Unit
This study is looking at a new way to find cancer earlier by testing blood or other body fluids, which could help patients get diagnosed more accurately and with less invasive methods, leading to earlier treatment options.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10933531 on NIH RePORTER |
What this research studies
This research focuses on liquid biopsy, a method that analyzes biomarkers in blood or other body fluids to detect cancer at an earlier stage than traditional methods. By examining circulating tumor cells, DNA, and other cancer-related substances, the study aims to improve the accuracy and effectiveness of cancer diagnosis. The project will also address challenges in validating new testing techniques across different populations and cancer types, ensuring that the findings are applicable and reliable. Patients may benefit from less invasive testing and potentially earlier treatment options.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at high risk for cancer or those with early-stage cancer who are undergoing diagnostic evaluation.
Not a fit: Patients with advanced-stage cancer or those who do not have cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier cancer detection, improving treatment outcomes and reducing mortality rates.
How similar studies have performed: Previous research has shown promise in using liquid biopsy for cancer detection, indicating that this approach has potential for significant advancements in early diagnosis.
Where this research is happening
Seattle, United States
- Fred Hutchinson Cancer Center — Seattle, United States (Active)
Researchers
- Principal investigator: Zheng, Yingye — Fred Hutchinson Cancer Center
- Study coordinator: Zheng, Yingye
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.